Local amplification of glucocorticoids in the aging brain and impaired spatial memory by Yau, Joyce L. W. & Seckl, Jonathan R.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Local amplification of glucocorticoids in the aging brain and
impaired spatial memory
Citation for published version:
Yau, JLW & Seckl, JR 2012, 'Local amplification of glucocorticoids in the aging brain and impaired spatial
memory' Frontiers in Aging Neuroscience, vol 4, 24, pp. 24. DOI: 10.3389/fnagi.2012.00024
Digital Object Identifier (DOI):
10.3389/fnagi.2012.00024
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Frontiers in Aging Neuroscience
Publisher Rights Statement:
Copyright © 2012 Yau and Seckl. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the
original authors and source are credited and subject to any copyright notices concerning any third-party graphics
etc.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
REVIEW ARTICLE
published: 29 August 2012
doi: 10.3389/fnagi.2012.00024
Local amplification of glucocorticoids in the aging brain
and impaired spatial memory
Joyce L. W. Yau* and Jonathan R. Seckl
Centre for Cognitive Ageing and Cognitive Epidemiology and Endocrinology Unit, Centre for Cardiovascular Science, The Queen’s Medical Research Institute,
University of Edinburgh, Edinburgh, UK
Edited by:
Emma R. Wood, University of
Edinburgh, UK
Reviewed by:
Jacques Micheau, University of
Bordeaux 1, France
Eric Blalock, University of Kentucky,
USA
*Correspondence:
Joyce L. W. Yau, Queen’s Medical
Research Institute, 47 Little France
Crescent, Edinburgh, EH16 4TJ, UK.
e-mail: joyce.yau@ed.ac.uk
The hippocampus is a prime target for glucocorticoids (GCs) and a brain structure
particularly vulnerable to aging. Prolonged exposure to excess GCs compromises
hippocampal electrophysiology, structure, and function. Blood GC levels tend to increase
with aging and correlate with impaired spatial memory in aging rodents and humans. The
magnitude of GC action within tissues depends not only on levels of steroid hormone
that enter the cells from the periphery and the density of intracellular receptors but also
on the local metabolism of GCs by 11β-hydroxysteroid dehydrogenases (11β-HSD). The
predominant isozyme in the adult brain, 11β-HSD1, locally regenerates active GCs from
inert 11-keto forms thus amplifying GC levels within specific target cells including in the
hippocampus and cortex. Aging associates with elevated hippocampal and neocortical
11β-HSD1 and impaired spatial learning while deficiency of 11β-HSD1 in knockout (KO)
mice prevents the emergence of cognitive decline with age. Furthermore, short-term
pharmacological inhibition of 11β-HSD1 in already aged mice reverses spatial memory
impairments. Here, we review research findings that support a key role for GCs with
special emphasis on their intracellular regulation by 11β-HSD1 in the emergence of spatial
memory deficits with aging, and discuss the use of 11β-HSD1 inhibitors as a promising
novel treatment in ameliorating/improving age-related memory impairments.
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INTRODUCTION
Cognitive decline is a key feature of aging but significant impair-
ments of learning and memory are not inevitable or strictly
linked to chronological age. Marked inter-individual variability
exists, ranging from almost no decline through mild impair-
ments to frank dementia. This phenomenon has been described
in several species including rodents and humans but the mecha-
nisms underlying the individual differences remain poorly under-
stood. One important mechanistic hypothesis is that variations
in hypothalamic-pituitary-adrenal (HPA) activity and conse-
quent exposure to glucocorticoids (GCs; cortisol in humans,
corticosterone in rodents) during life may contribute to the
inter-individual differences in cognitive decline in animals and
humans.
The adrenal cortex synthesizes GCs and these steroid hor-
mones are released directly into the peripheral circulation follow-
ing stimulation of the HPA axis in response to external (stress)
and internal (circadian) cues. Collectively, GCs released in coor-
dination with the rapidly acting sympathetic-adrenomedullary
system, help an organism respond to “stressors” or threats to
homeostasis by mobilizing energy stores, suppressing nonessen-
tial physiological processes (e.g., reproduction, digestion) and
initiating behavioral responses. Circulating GC levels are nor-
mally tightly regulated by negative feedback inhibition upon the
HPA axis where GCs act back on the hypothalamus and pitu-
itary glucocorticoid receptors (GRs) (to suppress CRH and ACTH
production) to terminate its own release. GC feedback also occurs
in higher centers such as the hippocampus and cingulate cortex.
GCs readily enter the brain, a major target for GC action
(McEwen et al., 1968). Here GCs bind to classical nuclear (hor-
mone) receptors to regulate the transcription of specific genes,
either by direct binding of receptor homodimers to DNA (Datson
et al., 2001) or via protein-protein interactions with other tran-
scription factors such as fos and Jun-1 (Heck et al., 1994; Hayashi
et al., 2004). Through activation of their intracellular receptors,
GCs affect a wide range of processes including altering neuro-
transmission, electrophysiological activity, cellular metabolism,
and structure, as well as neuronal division, maturation, and death.
CORTICOSTEROID RECEPTORS
Two types of corticosteroid receptors exist, the type I high affin-
ity mineralocorticoid receptors (MR) and type II lower affinity
GRs (Reul and de Kloet, 1985). Although sharing almost identi-
cal DNA-binding domains, MR and GR can exert distinct cellular
functions as the genes they bind to show little overlap (Datson
et al., 2001). GRs are widely distributed throughout the brain
in most neurons and glia. GRs have a lower affinity for phys-
iological GCs and only become substantially activated as hor-
mone levels rise following stress. MR is expressed in neurons
only and has a more restricted distribution with high expres-
sion confined particularly to the hippocampus (Figure 1), and
septum. MRs having a 10-fold higher affinity for physiological
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FIGURE 1 | Mineralocorticoid receptor (MR) and glucocorticoid
receptor (GR) mRNA expression in rat brain. The high affinity MR is
predominantly occupied under low corticosterone (CORT) levels typically
observed in young animals under basal conditions and this leads to
enhanced LTP and good memory. When CORT levels rises such as in
aging, MR is fully occupied and the excess GCs now occupy more GR so
the balance of receptors activated is now predominantly GR which
decreases LTP and impairs memory.
corticosteroids (GCs and the mineralocorticoid aldosterone) are
extensively occupied under basal conditions when hormone levels
are low (Reul and de Kloet, 1985; McEwen et al., 1986).
In addition to the delayed genomic effects via intracellular MR
and GR, it has become evident from recent work that GCs also
affect brain function through rapid non-genomic membrane-
associated mechanisms (Groeneweg et al., 2011) (Figure 2). The
latter mode of action explains the rapid (minutes) effects of
GCs on the excitability and activation of neurons in several
brain regions (e.g., hypothalamus, hippocampus, amygdala, and
prefrontal cortex) and provides a physiological basis for rapid
effects on behavior (de Kloet et al., 2008). A membrane-localized
form of MR appears to mediate the rapid GC signaling in the
hippocampus (Karst et al., 2005). However, not all rapid GC
effects occur via MRs with some [e.g., increase in spine density
of hippocampal neurons (Komatsuzaki et al., 2005)] depending
on membrane-located GRs rather than MRs and others [e.g.,
long-term potentiation (LTP) induction (Wiegert et al., 2006),
NMDA-dependent neurotoxicity (Xiao et al., 2010)] occurring
independent of MR or GR but mediated possibly through as yet
unidentified membrane-localized receptors.
BLOOD GLUCOCORTICOID LEVELS
Short term increases in GC levels are normally adaptive and bene-
ficial but prolonged exposure to elevated GC levels such as during
chronic stress or as a consequence of failure or impairment of
negative feedback control of GC secretion (e.g., Cushing’s syn-
drome, major depression) will lead to excessive GC responses
and to pathology in the periphery (e.g., diabetes, hyperten-
sion, osteoporosis, central obesity) and CNS (e.g., depression,
impaired learning, and memory). Cushing’s syndrome patients
with hyper-secretion of cortisol show reduced hippocampal vol-
ume and impaired performance on hippocampal learning tasks
(Starkman et al., 1992). Notably, successful treatment to correct
the excessive secretion of GCs reverses the pathology including
hippocampal structural recovery and the restoration, to some
extent, of mood, learning, and memory (Starkman et al., 1999).
Conversely, severely reduced GC levels, as in Addison’s disease,
also result in pathology and cognitive impairments (Tytherleigh
et al., 2004) and are treated with lifelong corticosteroid replace-
ment. Thus both too little and too much GCs can have detrimen-
tal effects on memory, emphasizing the crucial need to maintain
optimal levels of GCs for health and survival.
GLUCOCORTICOIDS AND HIPPOCAMPUS-DEPENDENT
MEMORY
GCs via binding to abundant MRs and GRs in the hippocampus
control the excitability of neuronal networks that underlie learn-
ing and memory processes. While not the focus of this review,
it is worth noting that other brain areas rich in GRs such as the
basolateral amygdala (BLA) and prefrontal cortex, which controls
emotional and working memory respectively, interacts with the
hippocampus to modulate cognitive function (Roozendaal and
McGaugh, 1997, 2011). An efficient interplay between activation
of MR and GR appears essential for maximal learning. The two
receptors have different roles in learning as evident from rodent
studies, especially in the watermaze using antagonists of MR and
GR at the various phases of spatial learning (Oitzl and de Kloet,
1992); MRs have a major role in behavioral reactivity toward
stimuli while GRs are involved in consolidating learned infor-
mation. Furthermore, the ratio of occupation and presumably
activation of MR/GR appears to determine whether GCs improve
or impairmemory (de Kloet et al., 1999). Thus, optimal enhanced
memory occurs whenGC levels aremildly elevated such that most
MRs and only some GRs are activated (i.e., increased MR/GR
ratio) but impaired memory results when circulating GC levels
are greatly increased such as found in some aging individuals
(i.e., low MR/GR ratio) (Kim and Diamond, 2002; Tytherleigh
et al., 2004; Herbert et al., 2006) (Figure 1). Indeed, circulating
basal (nadir) GC levels do not always increase as a function of
chronological age with only a proportion of individuals showing
increasingly high GC levels with advancing age while some show
levels within the young normal range (Lupien et al., 1994).
MR AND GR ACTIVATION
Whether the consequence of the receptor activation is positive
or negative for memory depend largely on the context of the
situation/event to be remembered, the timing and the magni-
tude of the increased GC levels (de Kloet et al., 1999; Joels
et al., 2006). Acute stress or increased GC levels occurring around
the time of learning and within the context of the event to be
remembered enhances memory consolidation. In contrast, they
impair memory if occurring either before or a considerable time
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FIGURE 2 | Schematic diagram showing stress hormone effects: from
cellular responses to behavior. Activation of the HPA axis by stress
leads to a rapid rise in circulating corticosterone (CORT) levels which starts
to fully occupy MR and increasingly occupy GRs. The varying level of
occupancy of MRs and GRs are represented by extent of shading or lines
within the boxes. The CORT levels normally return to baseline levels by 2 h
through negative feedback regulation upon the HPA axis. The initial rapid
effects of CORT via activation of membrane-located MRs enhance LTP
induction and enhance miniature excitatory postsynaptic currents in the
hippocampus while membrane-located GRs appear to increase neuronal
spine density. Together with other stress hormones released such as the
catecholamines (noradrenaline and adrenaline) and corticotropin-releasing
hormone (CRH), which also strengthen synaptic transmission in the
hippocampus, these rapid events contribute to enhanced vigilance, alertness,
and attention. The slower genomic effects of CORT through activation of
intracellular MRs and GRs and the transcription of target genes, leads to the
maintenance of glutamatergic transmission via MRs and suppression of LTP
induction but enhanced LTD via GRs in the hippocampus. MRs and GRs
contributes to different aspects of cognitive processing with MR activation
responsible for the appraisal of sensory information and environmental cues,
while GRs are important for the consolidation of events/information in
memory.
after the learning task (Quervain et al., 1998; Cazakoff et al.,
2010). Evidence, mainly from animal studies, suggests that GCs
preferentially enhances memory consolidation of emotionally
arousing experiences (Roozendaal et al., 2006). Animal learning
tasks, including the Morris watermaze and radial arm maze for
spatial memory training, are designed to be generally affectively
arousing because they require motivation to elicit changes in
behavior. Even learning tasks that include no rewarding or aver-
sive stimulation, such as the object recognition task, induces
modest novelty-induced stress or arousal during training (Okuda
et al., 2004). GCs released during learning appear essential for
establishing enduring memories (De Kloet et al., 1998). Thus,
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small increases in GCs enhance hippocampus-mediated learning
and memory while larger, prolonged elevations impair memory
(Lupien and McEwen, 1997; Kim and Diamond, 2002). This fol-
lows the inverted U-shaped dose-response relationship between
GC levels and effects on hippocampal LTP, an electrophysiologi-
cal phenomenon associated with synaptic strengthening which is
one of the major cellular mechanisms underlying learning and
memory. Low moderate GC levels occupy predominantly high
affinity MR which increases LTP and memory, while high GC
levels occupy the lower affinity GR (in addition to MR) and
impair LTP and memory (Pavlides et al., 1995, 1996; Kim and
Diamond, 2002; Kim et al., 2007). One recent study supports
the inverted-U-shaped relationship between intrinsic stress inten-
sity (i.e., increased endogenous GCs induced by factors associated
with the learning task, in this case water temperature) and spatial
memory in the radial arm watermaze. Thus, rats trained at 19◦C
made fewer errors than rats trained at either more (16◦C) or less
(25◦C) stressful conditions (Salehi et al., 2010).
THE AGING HIPPOCAMPUS
The hippocampus not only plays a central role in the processing
of spatial and contextual information (Morris et al., 1982; Moser
et al., 1995) but also exerts an inhibitory influence over HPA func-
tion (Jacobson and Sapolsky, 1991). With its high density of MRs
and GRs, the hippocampus is also particularly sensitive to the
deleterious actions of chronic GC excess, potentiating neurotoxi-
city, dendritic atrophy, and perhaps even neuronal loss (Sapolsky,
1987). The idea that excess GCs could promote aging of the hip-
pocampus was first established over 30 years ago following a study
that showed a positive correlation between hippocampal aging
(astrocyte reactivity as a marker of neuronal damage) and plasma
levels of corticosterone in aging rats (Landfield et al., 1978).While
only a few studies have shown high GC levels or stress actually
cause hippocampal neuron loss (Uno et al., 1989; Sousa et al.,
1998), much evidence support chronic stress (or high GCs) caus-
ing hippocampal atrophy (Watanabe et al., 1992; Magarinos and
McEwen, 1995).
In humans, including those with Cushing’s disease,
Alzheimer’s disease, depression, and normal aging, higher
cortisol levels have been associated with poorer memory and
hippocampal shrinkage/neuronal loss (De Leon et al., 1988;
Wolkowitz et al., 1990; Newcomer et al., 1994; Mitchell and
Dening, 1996; Lupien et al., 1998; Karlamangla et al., 2005;
MacLullich et al., 2005). Moreover, increased HPA activity, as a
consequence of impaired HPA axis negative feedback control, has
been hypothesized to contribute to the decline in cognitive func-
tion, including deficits on spatial tasks with aging (Ohta, 1981;
Lupien et al., 1998; McEwen et al., 1999). In support, the extent
of age-related cognitive impairments in rodents and humans
correlates with increased HPA activity (Issa et al., 1990; Meaney
et al., 1995; Yau et al., 1995; Lupien et al., 1996, 1998). Aging
rodents also show difficulty with hippocampus-dependent tasks
that require a spatial mapping strategy; acquisition deficits have
been reported in spatial information processing tests including
Barnes hole-board task, radial armmazes, and Morris watermaze
(Ingram et al., 1981; Barnes and McNaughton, 1985; Gage et al.,
1989; Issa et al., 1990; Gallagher et al., 1993; Yau et al., 1994, 1995).
GLUCOCORTICOIDS AND OTHER BRAIN SITES
Although GCs act on the hippocampus to modulate the for-
mation of new memories, it also acts at other sites, notably
the amygdala and prefrontal cortex, which functionally inter-
act. Thus, GC effects on hippocampal LTP and memory can be
blocked by lesions to the BLA (Roozendaal and McGaugh, 1997;
Kim et al., 2001) and much evidence supports a role of the BLA
via emotional arousal-induced noradrenergic activation and GR
actions in the modulation of memory consolidation and working
memory (Roozendaal and McGaugh, 2011). Given that amygdala
function is affected by aging (Iidaka et al., 2002; Charles et al.,
2003), it might be expected that fear conditioning would also
be disrupted with aging and hence influence hippocampal mem-
ory deficits. However, age-related impairments in spatial memory
appear not to be influenced by emotional and contextual mem-
ories, which tend to be preserved with aging (Comblain et al.,
2004; Gould and Feiro, 2005; May et al., 2005; Bergado et al., 2011;
Broster et al., 2012).
GLUCOCORTICOIDS AND INTER-INDIVIDUAL DIFFERENCES
IN SPATIAL MEMORY
AGED RATS
As a group, aged rats show impaired spatial learning. However,
there are substantial inter-individual differences in performance
(Yau et al., 1995). This increased variation in aged rats allows
subdivision into categories (cognitively-unimpaired, cognitively-
impaired) in the watermaze according to their latency to find
the submerged platform on the last days of training relative to
the mean latency of young controls (Issa et al., 1990; Tombaugh
et al., 2002) or to a learning index score computed from probe
trials (during retraction of the platform to the bottom of the
pool during 30 s of 90 s trials) (Gallagher et al., 1993; Wilson
et al., 2004; Robitsek et al., 2008). Aged rats have also been sub-
divided into impaired and unimpaired categories according to
their spatial memory performance in a Y-maze two-trial spa-
tial recognition task where the mean value of the percentage
of visits in the novel arm of impaired rats were not differ-
ent from chance values (Vallee et al., 1997). We typically find
approximately ∼20–25% of aged Lister hooded rat cohorts dif-
fer significantly (>2.5 SD) from young controls in the watermaze
(escape latency and probe times) and another ∼20–25% not sig-
nificantly different (<0.5 SD) from young controls (Figure 3).
It is the cognitively impaired groups that selectively show ele-
vated plasma corticosterone levels (Issa et al., 1990; Yau et al.,
1995), and reduced hippocampal corticosteroid receptor den-
sity (Issa et al., 1990; Yau et al., 1995) compared to both young
and similarly aged cognitively unimpaired rats (Issa et al., 1990).
While aged rats with watermaze performances not significantly
different from young rats have been sub-classed as “cognitively
unimpaired,” it is important to note that they are not cog-
nitively the same as young rats. Indeed, we found that aged
Lister hooded rats, categorized as unimpaired by their perfor-
mance in the conventional spatial memory watermaze task, were
impaired in a more cognitively demanding delayed matching-
to-place paradigm spatial memory watermaze task (Steele and
Morris, 1999) when compared to young controls (Yau and Seckl,
unpublished).
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FIGURE 3 | Aged Lister hooded rats show inter-individual differences in
spatial learning in the watermaze. 24 months old male Lister hooded rats
show impaired spatial learning and memory in the watermaze as a group
compared to 6 months old controls. However, individual performances
taking the median of the escape latencies (4 trials/day) for the last 2 days of
training shows a large spread of learning abilities for aged rats. Plasma
corticosterone (CORT) levels in the aged rats correlated negatively with
spatial memory with impaired aged rats showing increased CORT while
unimpaired aged rats had lower CORT similar to young controls (Based on
Yau et al., 1995, with permission from Elsevier).
AGED MICE
Aged mice also show impaired spatial memory in the water-
maze (Verbitsky et al., 2004; Pawlowski et al., 2009) and increased
plasma CORT levels (Yau et al., 2001, 2007; Holmes et al., 2010)
such that higher CORT levels correlates with impaired learn-
ing in the watermaze (Yau et al., 2001). However, in contrast
to aged rats, subdividing aged mice cohorts into cognitively
aged-impaired and aged-unimpaired groups is less clear-cut with
large variations in performance found even in young controls
(Pawlowski et al., 2009). Mice in general take longer to train in
the watermaze than rats and show less consistent performance
with some aged mice tending to float rather than swim. The Y-
maze spatial recognition task, in contrast to the watermaze, is an
ethologically relevant test based on the rodent’s innate curios-
ity to explore novel areas and presents no negative or positive
reinforcers and little stress for the rodents. When spatial mem-
ory was tested in the Y-maze using a 2 h inter-trial interval,
young C57BL/6J mice can still remember the novel arm (explor-
ing it more than the other two arms) while aged mice were
overall impaired as a group (not distinguishing the novel arm
between the three arms). As in the watermaze, inter-individual
differences in Y-maze spatial memory performances exist in aged
mice, but with a smaller percentage of aged mice “unimpaired”
(<20%) while the majority were “impaired” (Yau and Seckl,
unpublished).
GLUCOCORTICOIDS ANDMAINTAINENCE OF SPATIAL
MEMORY WITH AGING
In rats, manipulations which keep GC levels low throughout life,
such as postnatal handling during the first two weeks of life
(which permanently increases hippocampal expression of GR,
thus improving HPA axis negative feedback to reduce circulating
GC levels), denser maternal care (licking and arched back nurs-
ing of her offspring), or adrenalectomy at middle age with
low dose corticosterone replacement, prevent later hippocampal
morphological changes and spatial memory deficits with aging
(Landfield et al., 1981; Meaney et al., 1988). Although such
manipulations are probably not clinically utilizable, they sug-
gest that pharmacological treatments to increase GR density in
the adult hippocampus may reduce GC levels long-term and
ameliorate or prevent the emergence of spatial memory impair-
ments with aging. One potent long-term regulator of MR and GR
in the hippocampus is serotonin; this neurotransmitter directly
increases GR in primary neuronal cultures and in vivo follow-
ing postnatal handling of rat pups (Mitchell et al., 1990; Meaney
et al., 1994; Lai et al., 2003) while lesions of the serotonergic
pathway reduces hippocampal MR and GR (Yau et al., 1997).
Antidepressants, which amongst other effects, increases serotonin
levels, increase hippocampal GR density, improve HPA feedback
regulation and thus reduce GC levels in adult rats and mice (Reul
et al., 1993; Montkowski et al., 1995; Barden, 1996). Chronic (2
months) treatment of aged Lister hooded rats with amitriptyline,
however, did not prevent spatial memory impairments but treat-
ment of young (8 months) animals improved spatial memory,
reduced plasma corticosterone levels, and increased hippocam-
pal MR mRNA expression (Yau et al., 1995). Since hippocampal
MR enhances LTP (Pavlides et al., 1994) and has a positive
influence on memory while central MR blockade impairs spa-
tial memory in adult rats (Yau et al., 1999), the antidepressant
induced increase in hippocampal MR may, in part, underlie the
better spatial memory in the young rats. Aged rats may lack
the plasticity for antidepressants to be effective at enhancing
memory later in life. In support, earlier treatment with antide-
pressants frommiddle age (for 6months) improved HPA negative
feedback (Rowe et al., 1997) and reduced the emergence of spa-
tial memory impairments in a cohort of aged rats (Yau et al.,
2002).
TISSUE SELECTIVE REGULATION OF GLUCOCORTICOID
EXPOSURE
While many studies have measured blood GC levels and corre-
lated this to GC actions within tissues of interest, the principal
determinant of GC action is the level of hormone inside the cell.
The magnitude of intracellular GC action has long been thought
to be determined by the concentration of active hormone in the
circulation [modulated by hormone binding to plasma proteins,
mainly corticosteroid binding globulin (CBG)] and the density
of intracellular receptors in target tissues. However, during the
past two decades, enzymic pre-receptor metabolism of GCs by
11β-hydroxysteroid dehydrogenases (11β-HSDs) has emerged
as a key mechanism for tissue specific control of active GC
levels (Seckl, 1997). 11β-HSDs are microsomal (endoplasmic
reticulum) enzymes which catalyse the interconversion of active
GCs (corticosterone in rodents, cortisol in humans) and inert
11-keto forms [11-dehydrocorticosterone (11-DHC), cortisone].
They thus, potently regulate steroid access to receptors within
specific tissues (Seckl, 1997).
11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
11β-HSD1 is the predominant isoform in the adult rodent and
human brain, where it is widely distributed with particularly
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high expression in the hippocampus, cerebellum, and cortex in
both neurons and glia cells (Moisan et al., 1990; Sandeep et al.,
2004). 11β-HSD2 whilst highly expressed in the fetal CNS until
mid-gestation, in the adult brain is restricted to the nucleus of
the solitary tract (NTS) in mice and this plus a few other scat-
tered brain stem and diencephalic nuclei in rats. 11β-HSD2 acts
as a dehydrogenase to inactivate GCs before they can bind to
receptors. It is best noted for its role to exclude GCs from oth-
erwise non-selective MRs in the distal nephron, thus allowing
aldosterone selectivity. 11β-HSD1 in contrast functions as a 11β-
reductase (regenerating active GCs from inert 11-DHC) in intact
cells, thus locally “amplifying” GC levels within brain cells as well
as in liver, adipose tissue, immune system cells etc (Figure 4).
This direction of action, far from protecting neurons against
GC excess, would be anticipated to increase local intraneuronal
GC levels, potentiating their effects including toxicity. Consistent
with this hypothesis, in vitro otherwise inert 11-DHC potenti-
ates kainate neurotoxicity in hippocampal cells in culture, as a
consequence of its conversion to active corticosterone by 11β-
HSD1 expressed in the neurons, an effect lost in the presence
of an 11β-HSD inhibitor (Rajan et al., 1996). The importance
of such regeneration of GCs within cells in vivo was shown in
mice homozygous for targeted disruption of the 11β-HSD1 gene
(Kotelevtsev et al., 1997). 11β-HSD1 appears to be the only 11β-
reductase, at least in mice, since knockout (KO) animals cannot
convert 11-DHC to active corticosterone and showed evidence
of reduced tissue GC actions (e.g., resist hyperglycaemia induced
by obesity or stress) (Kotelevtsev et al., 1997). So are there brain
effects of 11β-HSD1 deficiency?
11β-HSD1 AND HPA AXIS ACTIVITY
Expression of 11β-HSD1 in brain sites (prefrontal cortex, hip-
pocampus, hypothalamus) and pituitary that underpin negative
feedback actions of GCs suggests that this enzyme may influ-
ence HPA axis activity. In order to maintain tissue GC levels in
feedback sites that normally express 11β-HSD1, higher levels of
plasma GCs would be predicted to result as a consequence of
loss of local production of active GCs at these sites. Indeed mice
lacking 11β-HSD1 on the 129/MF1 strain showed evidence of
reduced HPA axis feedback sensitivity (elevated nadir levels of
plasma corticosterone, enlarged adrenal glands, and exaggerated
GC response to an acute stressor) (Harris et al., 2001). However,
FIGURE 4 | Regulation of glucocorticoid (GC) levels in blood and tissues.
Circulating GC levels are tightly regulated by negative feedback inhibition at
the hypothalamic-pituitary-adrenal (HPA) axis. Active GCs (cortisol in humans,
corticosterone in rodents) circulate mostly bound to CBG (corticosteroid
binding globulin) such that only ∼4% are free to enter tissues. The inactive
GCs (cortisone, 11-dehydrocorticosterone) the products of 11β-HSD2
metabolism mainly in kidney, circulates unbound to plasma proteins so all are
available to enter tissues. Once inside the cell, there is another level of
control by the presence of 11β-HSD1 (found in specific cells in the adult brain
such as in hippocampus and cortex and other tissues such as liver and
adipose). 11β-HSD1 regenerates active GCs from their inactive forms thereby
effectively amplifying intracellular GC levels before they bind to MR and/or
GR (depending on brain region). The activated receptors then translocate into
the nucleus to activate the transcription of target genes.
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the effects of 11ß-HSD1 deficiency on HPA axis activity were lost
when the mice were bred onto another genetic background strain.
Thus, 11β-HSD1 KO mice congenic on a C57BL/6J background
show normal nadir plasma corticosterone levels and efficient neg-
ative feedback regulation thought to be due to compensatory
increased GR expression in the hippocampus and paraventricu-
lar nucleus of the hypothalamus (Carter et al., 2009). Activation
of the HPA axis is therefore not an inevitable consequence of 11β-
HSD1 deficiency or inhibition. The genetic background appears
crucial in governing the HPA axis response to 11β-HSD1 defi-
ciency or inhibition.
IMPLICATIONS OF 11β-HSD1 FUNCTION IN THE AGING
BRAIN
If 11β-HSD1 locally regenerates active GCs thus amplifying GC
action within specific cells in vivo, this direction of enzyme activ-
ity would be anticipated to impair spatial memory in the aging
brain when there is the additional contribution of increased “free”
unbound GCs from the periphery in individuals with elevated
blood GC levels. Indeed, a lack of the enzyme in the aged brain
appears beneficial to memory processes as shown in 11β-HSD1
KO mice (Yau et al., 2001). Thus, aged 11β-HSD1 KO mice
congenic on the 129 strain, despite modestly elevated plasma cor-
ticosterone levels throughout life, show ameliorated GC-related
learning impairments in the watermaze (Yau et al., 2001). This
is the opposite of what would be anticipated if only circulating
corticosterone levels were taken into consideration. Hippocampal
tissue corticosterone levels measured ex-vivo were significantly
lower in aged 11β-HSD1 KO mice than aged controls (Yau et al.,
2001, 2011), supporting the important role the enzyme plays in
determining the levels of GCs within cells and thus their action.
AGED 11β-HSD1 KNOCKOUT MICE
Different genetic background mouse strains can exhibit marked
differences in learning and memory (Owen et al., 1997). The
original 11β-HSD1 KO mice generated on the 129 Ola back-
ground learnt a cued version of a watermaze task (Yau et al.,
2001), but had difficulty learning the classical task. Subsequently,
aged 11β-HSD1 KO mice congenic on the C57BL/6J back-
ground, the strain of choice in many behavioral tests, also
showed an improved cognitive phenotype resisting the spatial
memory impairments observed in many aged control mice, this
time observed in the standard reference memory watermaze and
also Y-maze spatial recognition tasks (Yau et al., 2007). Even a
50% reduction in 11β-HSD1 in heterozygous 11β-HSD1 KOs is
enough to prevent age-related spatial memory impairments (Sooy
et al., 2010).
INCREASED HIPPOCAMPAL 11β-HSD1 AND IMPAIRED SPATIAL
MEMORY
Aged C57BL/6J mice showed increased 11β-HSD1 expression in
the cortex (layer V) and CA3 cells of the hippocampus com-
pared to young controls. Moreover, hippocampal and cortical
11β-HSD1 mRNA levels correlate with impaired spatial learning
in the watermaze (Holmes et al., 2010). The selective increase of
11β-HSD1 in the CA3 subregion of the memory-impaired hip-
pocampus may be of functional significance since it is the CA3
cells that undergo dendritic atrophy following chronic restraint
stress or corticosterone injections (Magarinos and McEwen,
1995), both of which impair spatial memory (Luine et al.,
1994; Conrad et al., 1996; Wright and Conrad, 2005; Hoffman
et al., 2011). CA3 appears crucial for memory acquisition and
consolidation in the watermaze (Florian and Roullet, 2004).
Furthermore, CA3 cells selectively fail to rapidly encode new spa-
tial information in memory-impaired aged rats (Wilson et al.,
2005). This suggests that the implied increase of GC levels driven
by variable overexpression of 11β-HSD1 in CA3 of agedmice may
be a major contributor to the spatial memory deficits with aging.
The mechanisms underlying the upregulation of 11β-HSD1 in
CA3 and cortex of agedmice are unknown. GCs and stress elevate
hippocampal 11β-HSD1 in young animals affording a possible
feed-forward system to amplify GC action (Low et al., 1994).
Consistent with increased 11β-HSD1 levels in the hippocampus
impairing memory with aging, transgenic mice overexpress-
ing 11β-HSD1 in the forebrain under the CAMIIK promoter
resulting in 50% increase in the hippocampus, developed pre-
mature memory impairments with deficits in hippocampus-
dependent learning tasks (watermaze spatial reference memory
and passive avoidance memory) at 18 months (Holmes et al.,
2010).
HIPPOCAMPAL PLASTICITY AND AGING
LTP AND LTD
In the absence of hippocampal neuron loss, age-related spa-
tial learning deficits in rats may be the result of more subtle
changes in synaptic structure or function (Rapp and Gallagher,
1996; Smith et al., 2000). Consistent with this idea, impaired hip-
pocampal synaptic plasticity, specifically LTP in aged rats relates
to individual differences in spatial learning ability (Deupree
et al., 1991; Bach et al., 1999). Indeed, LTP induced in the
CA1 region using theta-frequency stimulation (5Hz) was selec-
tively impaired in hippocampal slices from a subpopulation
of aged rats that had previously shown poor spatial learning
in the water maze (Tombaugh et al., 2002). Elevated corticos-
terone levels (presumably occupying both MR and GR) also
impairs Primed Burst Potentiation (PBP), a low threshold form
of LTP, in the hippocampal CA1 in the rat, while low levels of
corticosterone (that would occupy mostly MRs) facilitates PBP
(Diamond et al., 1992). Although the involvement of other hor-
mones and/or brain regions may also play a role, high levels of
corticosterone directly impairs hippocampal synaptic potentia-
tion (Alfarez et al., 2002). In addition, induction of long-term
depression (LTD), which in contrast to LTP weakens rather
than strengthens synaptic contacts by repeated stimulation (Bear
and Malenka, 1994), is enhanced by high corticosterone levels
(Coussens et al., 1997) and during aging (Norris et al., 1996,
1998).
PRIMED BURST POTENTIATION
Primed burst stimulation induces lower potentiation in the
hippocampus of young animals compared to the LTP induc-
tion protocol (Diamond et al., 1994, 1996; Alfarez et al.,
2002), but few reports have shown this reliably in aged ani-
mals (Moore et al., 1993). We found very little PBP (a single
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200Hz stimulus followed 180ms later by a burst of four stim-
uli at 200Hz) in hippocampal slices from either 25 months
old 11β-HSD1 KO or age matched controls. However, LTP
induced with a single 100Hz tetanus, was increased in hip-
pocampal slices from aged 11β-HSD1 KO mice compared to
aged-matched C57BL/6J controls (Yau et al., 2007). Thus, an
increase in LTP in the hippocampus of aged 11β-HSD1 KO
mice may, in part, underlie their retention of spatial memory
with age.
GLUCOCORTICOIDS, NEUROGENESIS, AND AGING
Adult neurogenesis, the generation of new neurons via mitotic
cell division, occurs in the dendate gyrus of the hippocampus
throughout life. Although the full functional significance of these
new neurons is not fully understood, there is increasing evi-
dence to support the notion that these newborn neurons can
mature, form synapses, integrate with the local circuitry, and
are involved in hippocampus-dependent learning (Lemaire et al.,
2012; Marin-Burgin and Schinder, 2012). Of relevance to aging,
high levels of GCs or stress reduce neurogenesis (Czeh et al.,
2002; Wong and Herbert, 2006). Indeed, neurogenesis is substan-
tially reduced with aging in rodents (Seki and Arai, 1995; Kuhn
et al., 1996) and this may be in part related to increased GC
levels since within a cohort of aged rats, those with the highest
GC levels had the lowest levels of neurogenesis (Montaron et al.,
2006). Furthermore, when aged rats were subdivided into aged
unimpaired and aged impaired according to their spatial learning
abilities (the top and bottom 30%of the population), cell prolifer-
ation in the granule cell layer of the dentate gyrus correlated with
spatial memory performances (Drapeau et al., 2003). However,
when neurogenesis was examined in the aged 11β-HSD1 KO,
there was no significant difference compared to aged C57BL/6J
controls, although an increase in neurogenesis was observed in
young 11β-HSD1 KO mice (Yau et al., 2007). This suggests that
the maintained spatial memory in the aged 11β-HSD1 KO mice
is not a consequence of increased neurogenesis and that reduced
intrahippocampal GCs is insufficient to overcome the other fac-
tors linked with aging (e.g., decreased serotonin) that regulate
neurogenesis.
11β-HSD1 INHIBITORS ANDMAINTENANCE OF SPATIAL
MEMORY WITH AGING
Since aged mice with complete or partial 11β-HSD1 deficiency
throughout life are protected from spatial memory impairments
(Yau et al., 2007; Sooy et al., 2010), inhibiting 11β-HSD1 activ-
ity might benefit cognitive function in the aging brain. The
big question is can short-term pharmacological inhibition of
11β-HSD1 have memory-enhancing effects in aged rodents and
humans? In vivo studies in humans are hampered by the non-
selectivity of the originally available liquorice-based inhibitors.
Carbenoxolone, an old drug formerly used clinically to treat
peptic ulcers, inhibits both 11β-HSD1 and 11β-HSD2. This
may not matter in the adult brain as the predominant isozyme
is 11β-HSD1. Initial small exploratory studies, albeit random-
ized, double-blind, and placebo-controlled in healthy elderly
men and middle-aged patients with type 2 diabetes (52–75
years) showed that carbenoxolone improved aspects of cognitive
function (verbal fluency and verbal memory) after 4–6 weeks
treatment (Sandeep et al., 2004). Note that amilioride was also
given to prevent renal mineralocorticoid excess and hence hyper-
tension. This gave the first indication that inhibition of 11β-HSD1
(assuming the effects were centrally mediated) may be a promis-
ing new approach to prevent/ameliorate cognitive decline in
humans.
SELECTIVE 11β-HSD1 INHIBITION
Selective 11β-HSD1 inhibitors that can cross the blood brain bar-
rier have recently been developed (Webster et al., 2007). Two
weeks peripheral treatment with a CNS active selective 11β-
HSD1 inhibitor (UE1961) in aged C57BL/6J mice improved
spatial memory in the Y-maze compared to vehicle treated age-
matched controls (Sooy et al., 2010). Moreover, intracerebroven-
tricular administration of another selective 11β-HSD1 inhibitor
(UE2316) for 2 weeks also reversed spatial memory impair-
ments in aged C57BL/6J mice confirming mediation by brain
11β-HSD1 inhibition (Yau et al., unpublished). Thus, spatial
memory impairments in aged mice are not always a consequence
of irreversible brain structural changes and the effects of the
inhibitor are most likely the consequence of reduced intracellu-
lar GC levels during spatial learning and recall. Previous studies
have shown that it is the consequence of increased GCs as a
result of hippocampal structural changes (e.g., chronic stress-
induced dendritic atrophy) impairing HPA axis feedback that has
the more important influence on spatial memory performance
since such impairments can be prevented on the day of testing
by blocking GC synthesis (Roozendaal et al., 2001; Wright et al.,
2006).
OTHER POTENTIAL EFFECTS OF 11β-HSD1 INHIBITORS
Depending on the duration of treatment, selective 11β-HSD1
inhibitors may result in resistance of target tissues to GCs,
including HPA axis regulatory centers of the brain and pitu-
itary. This could lead to compensatory activation of the HPA
axis in an attempt to compensate for the GC deficiency in neg-
ative feedback loci expressing 11β-HSD1 in a similar manner
to that observed in 11β-HSD1 KO mice on the 129 genetic
background (Harris et al., 2001). A hyperactive HPA axis
would lead not only to excess plasma cortisol, but perhaps
also to excess mineralocorticoid precursors (corticosterone and
deoxycorticosterone) and androgens, all of which may mani-
fest as unwanted side effects, such as hypertension and hir-
sutism/hyperandrogenization in women. The degree of HPA axis
activation may depend on the genetic background of the indi-
vidual, as in mice, as well as the levels of 11β-HSD1 in these
tissues, which may differ under various environmental condi-
tions (e.g., with stress, diet, aging). There is also the question
of whether inhibition of 11β-HSD1 will affect other types of
memory other than spatial memory in cognitively impaired
aged individuals. In particular, emotional and fear associated
memories, involving the basolateral amygdala, are known to be
enhanced with increased GCs (Roozendaal and McGaugh, 2011).
Hence, 11β-HSD1 inhibitors may compromise the strength of
such memories but whether this is the case remains to be
determined.
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MAINTENANCE OF SPATIAL MEMORY WITH AGING VIA
PREDOMINANT MR ACTIVATION
Impaired spatial memory in aged C57BL/6J mice correlates with
higher plasma GCs which are thought to activate the lower affin-
ity GR. Indeed central blockade of GR (but not MR) for 2 weeks
reversed the impaired spatial memory in aged C57BL/6J mice
in the Y-maze (Yau et al., 2011). This again suggests that the
impaired memory in aged C57BL/6J mice is not a direct conse-
quence of irreversible structural changes. The improved spatial
memory in aged 11β-HSD1 KO mice has been proposed to occur
via reduced intracellular GC levels altering the balance of receptor
activation in favor of MR activation. In support, central block-
ade of MR but not GR in aged 11β-HSD1 KO mice reversed their
improved spatial memory phenotype such that they were now
impaired in the Y-maze (Yau et al., 2011). Therefore, decreasing
GR/increasing MR activation appears effective at preventing spa-
tial memory impairments even in already aged mice. Reducing
GC action by altering the receptor balance from predominant
GR activation to predominant MR activation may be achieved
by the use of selective 11β-HSD1 inhibitors or GR antagonists.
Long-term treatment with GR antagonists in humans, however,
may potentially cause compensatory activation of the HPA axis
to overcome the blockade thus producing generalized GC resis-
tance (Bamberger and Chrousos, 1995). While the use of selective
11β-HSD1 inhibitors causes compensatory activation of the HPA
axis simply to accommodate the reduced regeneration of GCs, ele-
vation of cortisol levels was not observed with carbenoxolone in
elderly humans (Sandeep et al., 2004) or with selective 11β-HSD1
inhibitors in clinical trials (Rosenstock et al., 2010). Similarly,
corticosterone levels were not increased in aged C57BL/6J mice
treated short-term with a selective 11β-HSD1 inhibitor (Sooy
et al., 2010).
LINKS BETWEEN COGNITION AND GLUCOSE METABOLISM
GCs play a role in the regulation of peripheral glucose mobiliza-
tion and metabolism. Much less is known about the effects of
GCs on glucose metabolism in brain tissues. GCs inhibit glucose
utilization in the hippocampus (Sapolsky, 1986). Adrenalectomy
decreases serum glucose levels and increases hippocampal glu-
cose utilization (Kadekaro et al., 1988). While exogenously
administered GCs adversely affect human memory consolidation
and recall (Newcomer et al., 1994), glucose improves memory
performance in normal elderly individuals (Hall et al., 1989)
and in subjects with probable Alzheimer’s disease (Craft et al.,
1993). Studies in rodents suggest that hyperglycemia and high-
fat diets adversely affect hippocampal function (Kamal et al.,
2000; Molteni et al., 2002). In humans, hyperglycemia associate
with decline in cognitive function with aging (Convit et al.,
2003). Since 11β-HSD1 KO mice lack the enzyme in all tis-
sues, it is possible that the cognitive protection in aged 11β-
HSD1 KO mice may reflect, in part, their improved metabolic
profiles (Kotelevtsev et al., 1997; Morton et al., 2001), rather
than solely the direct effects of enzyme deficiency in the brain.
However, aged 11β-HSD1 KO mice show no significant differ-
ence in glucose tolerance compared to age-matched controls (Yau
et al., 2007). Moreover, the 11β-HSD inhibitor carbenoxolone
improved cognitive function in aged humans without altering
plasma glucose levels (Sandeep et al., 2004). Thus, the implication
is that direct CNS effects of 11β-HSD1 deficiency or inhibition
are more likely responsible for the observed improved cognitive
function.
HIPPOCAMPAL GENE EXPRESSION ASSOCIATEDWITH
11β-HSD1 DEFICIENCY ANDMAINTENANCE OF
SPATIAL MEMORY WITH AGING
To further our understanding of how GC action affects age-
related memory performance, it will be important to determine
the downstream genes/pathways activated by hippocampal MR
and GRs that leads to the impaired and improved spatial mem-
ory of aged mice with and without 11β-HSD1. Several studies
have examined hippocampal gene expression changes associated
with age-related cognitive decline in rats and mice (Burger et al.,
2007; Rowe et al., 2007; Pawlowski et al., 2009). Using microar-
rays, many hippocampal genes were found to be altered with
aging regardless of cognitive status. Down-regulated genes in
rat hippocampus are involved in mitochrondrial function, cell
signaling, neural plasticity, and synaptic function whereas up-
regulated genes underpin inflammation, glial structure, choles-
terol transport, and lipid/protein degradation. Genes selectively
downregulated in spatial memory impaired aged rats character-
ized in the watermaze and culled soon after training include a
number of immediate early genes (IEGs) such as Arc and Zif268
(also called Egr-1 and NGFI-A) and glucose ultilization/insulin
signaling genes such as Irs1, GcK, and Insr (Rowe et al., 2007).
Zif268, is thought to activate the transcription of genes essen-
tial for hippocampus-dependent long-term memory (Jones et al.,
2001). Reduced resting levels of Zif268 mRNA in the CA1 hip-
pocampal area of aged rats with impaired spatial learning have
been observed by microarray analysis and in situ hybridization
histochemistry (Yau et al., 1996; Blalock et al., 2003). Whether the
selective alterations in gene transcription in cognitively impaired
but not unimpaired aged animals is related to their HPA activ-
ity and hence circulating GC levels is not known. Hippocampal
gene expression microarrays and proteomic approaches in behav-
iorally defined aged mice including aged 11β-HSD1 KO mice
and animals given selective 11β-HSD1 inhibitors may indicate
new drug targets for the enhancement of memory in the aged
individual.
NEUROSTEROIDS, CYP7B1, AND SPATIAL MEMORY
WITH AGING
Recent studies have revealed additional substrates for 11β-
HSD1. These include additional functions in the metabolism
of neurosteroids such as dehydroepiandrosterone (DHEA) and
pregnenolone, metabolism of 7-oxysterols, as well as in the detox-
ification of various xenobiotics (Odermatt and Nashev, 2010).
Neurosteroids have long been implicated to play an important
role in the modulation of spatial learning and memory processes
(Vallee et al., 2001). Circulating levels of DHEA derive from the
adrenal cortex and decline significantly with aging in humans and
this parallels cognitive decline (Orentreich et al., 1992). In rodents
there is very little DHEA in brain because they lack adrenal
expression of the enzyme cyp17α that converts pregnenolone to
DHEA (Le Goascogne et al., 1991) though there may be limited
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local CNS synthesis (Liu et al., 2009). However, high levels of its
precursor pregnenolone have been measured in the hippocampus
of young rats and this declines with aging correlating with spatial
memory impairments (Vallee et al., 1997). Pregnenolone, DHEA,
and related 3β-hydroxysteroids are 7α-hydroxylated in brain by
the cytochrome P450-7B1 (CYP7B1) enzyme into their bioactive
steroid metabolites (Rose et al., 1997). High levels of CYP7B1
is expressed in the hippocampus and enzyme activity is selec-
tively decreased in aged rats with impaired spatial memory but
not in aged cognitively unimpaired rats (Yau et al., 2006). In the
memory-impaired aged rats, central administration of an active
product, 7α-hydroxypregnenolone, reversed the spatial memory
deficits and improved memory in a radial arm watermaze mem-
ory task thus effectively overcoming reduced CYP7B1 activity
in the aged brain (Yau et al., 2006). It has recently been pro-
posed that the products of CYP7B1, 7α-hydroxypregnenolone,
and 7α-hydroxyDHEA, may exert anti-GC effects in target tis-
sues by competing with 11-keto GCs for access to 11β-HSD1,
thus attenuating regeneration of active GCs (Muller et al., 2006a).
Thus, 11β-HSD1, in addition to its known role in reactivating
GCs within target cells, has also been shown to carry out the
inter-conversion of 7α-hydroxyDHEA into 7β-hydroxyDHEA, at
least in vitro (Muller et al., 2006b) (Figure 5). Enzyme kinetic
data from yeast-expressed human 11β-HSD1 implies that the
7-hydroxysteroid substrates are preferred to cortisone. Hence
in tissues, 7-hydroxysteroid substrates may act like endogenous
“inhibitors” of 11β-HSD1, reducing their regeneration of active
GCs. This adds another level of potential fine tuning of GC action
within specific target CNS cells but whether this occurs in vivo
under normal or pathological conditions is not known.
CONCLUSIONS
The local amplification of GC action in the brain by 11β-HSD1
plays a pivotal role in the emergence of spatial learning impair-
ments with aging. Evidence over the past decade has confirmed
that while elevated plasma GCs correlate with impaired spatial
learning with aging, it is the level of active GCs within specific
brain cells regulated by 11β-HSD1 that appears essential for
the control of spatial memory in the aged animal. Importantly,
whereas treatments to lower blood GC levels need to be main-
tained long-term to ameliorate spatial memory deficits in aged
rats, lowering GC levels inside cells expressing the enzyme by
selective 11β-HSD1 inhibitors requires only short-term treatment
and can reverse spatial memory deficits in already aged mice.
Whether this is the case in humans remains to be tested. The data
also show that spatial memory deficits in aged rodents are not
necessarily irreversible due to structural changes but appear to be
regulated in the short-term by intracellular GC actions activat-
ing MR and GR to regulate the transcription of target genes that
influence memory formation. Future investigations to determine
FIGURE 5 | 7α-Hydroxylated steroids are also substrates for 11β-HSD1.
Both 11β-HSD1 and CYP7B1 are expressed in the rodent and human
hippocampus. CYP7B1 7α-hydroxylates pregnenolone (PREG) and
dehydroepiandrosterone (DHEA) into their more active 7α-hydroxylated
metabolites which are also substrates for 11β-HSD1. If levels of these
7α-hydroxylated metabolites within specific cells become high enough, they
may compete with the inactive GCs for 11β-HSD1 and effectively act as
endogenous “inhibitors” of 11β-HSD1 amplification of intracellular GC action.
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the mechanisms whereby 11β-HSD1 in the brain is upregulated
by aging and the downstream pathways following predominant
brainMR activation in aged 11β-HSD1 KOmice will be crucial in
the understanding of how GCsmaintain or impair hippocampus-
dependent spatial learning and memory with aging. Whether
or not this approach is of utility in pathological brain aging,
such as Alzheimer’s disease and other dementias, remains to be
determined, but of substantial interest.
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